ANDA 203352, held by Jubilant Cadista. Sodium Chloride.
As of Nov 15, 2026, ANDA 203352 (Sodium Chloride 0.9% In Plastic Container), held by Jubilant Cadista, was first approved by FDA on May 18, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 18, 2016 | Original application | Approved |
| Sodium Chloride 0.9% In Plastic Container90MG/10ML (9MG/ML) · solution;injection | Sodium Chloride | Discontinued |
| Sodium Chloride 0.9% In Plastic Container27MG/3ML (9MG/ML) · solution;injection | Sodium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
